Navigation Links
LS9, Inc. Appoints Bill Haywood Chief Executive Officer

SOUTH SAN FRANCISCO, Calif., Oct. 8 /PRNewswire/ -- LS9, Inc., the Renewable Petroleum Company(TM), today announces it has appointed Bill Haywood as Chief Executive Officer. Mr. Haywood brings over 30 years of experience in the fuels manufacturing business and a proven track record of planning, engineering, execution and start-up of major projects within the energy sector.

"The coming year will be pivotal to LS9 as the company delivers significant achievements in the development of second-generation biofuels," said Noubar Afeyan, Managing Partner of Flagship Ventures and Chairman of the LS9 Board of Directors. "Bill brings with him the ideal combination of project development, organizational optimization and investment management expertise the company needs as it transitions from development to production. His extensive relationships in the transportation fuels sector and his deep understanding of strategic partnerships are an ideal complement to the talented scientific team at LS9. The Board is extremely pleased to have Bill at the helm of the company."

Prior to joining LS9, Mr. Haywood served as Senior Vice President of Refining for Tesoro Petroleum, where he was responsible for seven refineries and over $20 billion in revenue. Under his leadership, Tesoro became a leading independent refiner by integrating refinery acquisitions, driving operational excellence and building over $1 billion in capital projects. During this period, shareholder value increased by more than 86%.

"I can't think of a more exciting opportunity than joining LS9 as we prepare to move this important technology to commercial production and become the first advanced biofuels company to reach the market," said Mr. Haywood. "I look forward to merging knowledge of the traditional transportation fuels business with synthetic biology to help bring LS9's renewable fuels and chemicals into the pipeline and to the consumer."

About LS9

LS9, Inc., the Renewable Petroleum Company(TM), is a privately-held industrial biotechnology company pursuing the commercial development of renewable fuels and chemicals. LS9 is applying synthetic biology to produce proprietary biofuels that are compatible with existing fuel distribution and consumer infrastructure and high value industrial chemicals. LS9 is the pioneer in the commercial development of fermentation derived hydrocarbon biofuels and its patent-pending Renewable Petroleum(TM) products are custom engineered in the lab to address immediate market needs for clean energy alternatives to petroleum. The company was founded in 2005 and venture capital firms Flagship Ventures, Khosla Ventures, and Lightspeed Venture Partners have provided funding to date. LS9 is headquartered in South San Francisco, California.

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board
2. CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities
3. Orexigen(R) Therapeutics Appoints Dennis Kim, M.D., as Senior Vice President, Head of Obesity and Metabolic Disorders
4. Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
5. ACORN Contract Research Organization Appoints Tara Webb as Senior Director of CRO Business Development
6. Neurofocus Appoints Stephen Kosslyn to Its Advisory Board
7. Cytochroma appoints Steven I. Engel as Vice President of Regulatory Affairs and Quality Assurance
8. Exosome Diagnostics Appoints Johan Skog, Ph.D., as Director of Genetics Research
9. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
10. China Yingxia International, Inc. Appoints New Vice President of Finance
11. SoluBest Appoints Michael Sheckler, MBA, as CEO
Post Your Comments:
(Date:11/26/2015)... , England , November 26, 2015 /PRNewswire/ ... Medical, an innovative medical device company specializing in imaging technologies, ... from the European Commission as part of the Horizon 2020 ... company to carry out a large-scale clinical trial in breast ...      (Logo: , --> ...
(Date:11/25/2015)... 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced ... stockholder rights plan (Rights Plan) in an effort to ... (NOLs) under Section 382 of the Internal Revenue Code ... PharmAthene,s use of its NOLs could be substantially limited ... in Section 382 of the Code. In general, an ...
(Date:11/25/2015)... 25, 2015 Studies reveal the ... plaque and pave the way for more effective treatment for ...     --> --> ... health problems in cats, yet relatively little was understood about ... studies have been conducted by researchers from the WALTHAM Centre ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. ... Gorman , President and CEO of Neurocrine Biosciences, will ... Conference in New York . ... visit the website approximately 5 minutes prior to the ... replay of the presentation will be available on the ...
Breaking Biology Technology:
(Date:10/29/2015)... 29, 2015 NXTD ) ... focused on the growing mobile commerce market and ... StackCommerce, a leading marketplace to discover and buy ... smart wallet on StackSocial for this holiday season. ... the "Company"), a biometric authentication company focused on ...
(Date:10/27/2015)... 2015 Munich, Germany ... technology (ASGM) automatically maps data from mobile eye tracking ... , so that they can be quantitatively analyzed with ... Munich, Germany , October 28-29, 2015. SMI,s Automated ... mobile eye tracking videos created with SMI,s Eye ...
(Date:10/26/2015)... LAS VEGAS , Oct. 26, 2015 ... in modern authentication and a founding member of the ... its latest version of the Nok Nok™ S3 Authentication ... standards-based authentication that supports existing and emerging methods of ... ideal for organizations deploying customer-facing applications that require Internet ...
Breaking Biology News(10 mins):